Notice

HOME / Notice / News / EN

EN

“NKCL will lead the popularization of Immune-Therapy using NK cells” FILE HOT

“We will build up Personalized-Immune Care Platform by enhancing people’s health using NK immune cell, as well as various products and programs.” said Shin Dong-Hwa the chairman of NKCL Bio Group. NKCL Bio Group researches and develops immune cell therapy using NK immune cells based on its excelle...

NKCL | 2020.09.08 | 조회 3231

NKCL Bio Group signed MOA with Qingdao Orthopedic Hospital for cooperation on Cell Culture. FILE HOT

NKCL Bio Group Inc. has signed MOA on April 27 with Qingdao Orthopedic Hospital (颐生健骨伤医院) , a hospital affiliated with China-TSRH Association in China, for business cooperation. In line with the social distancing, the MOA signing was held in the form of real-time video conference, and the numb...

NKCL | 2020.09.03 | 조회 2266

NKCL Bio Group will accelerate the cell therapy business in accordance with the implementation of the Advanced Regenerative Medicine Act FILE HOT

NKCL Bio Group, a Korean bio-company that research and develops immune cell therapy, is attracting attention as a beneficiary company of ‘the Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Bio-Pharmaceuticals' (hereinafter referred to as the Advanced Medicine Act). The ...

NKCL | 2020.08.31 | 조회 2057

The Proposal for Advanced Regenerative Bio Law Enforcement Ordinance has passed the Cabinet meeting. “Uncertainties have been resolved for Bio Industry to boost the R&D” FILE HOT

The Ministry of Food and Drug Safety and the Ministry of Health and Welfare announced on the 25th that the enactment of the Enforcement Decree of ‘The Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Biopharmaceuticals' has passed the cabinet meeting. The Advanced Regener...

NKCL | 2020.08.27 | 조회 1886

NKCL Bio Group to open “NK Immune Cafe” on 70 locations in Korea, to lead the immune care market. FILE HOT

As a company that researches immune cell therapy using NK immune cells, NKCL Bio Group targets the $100 billion Immune cell therapy market through its differentiated technological competitiveness. It is leading the mass production and popularization of NK Immune Cell and products through a GMP certif...

NKCL | 2020.08.21 | 조회 1930
처음 이전  11 12 13 14 15 16 [ 17 ] 18 19 20  다음 마지막